Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China
Clinical trial NCT02458651 · COMPLETED
Trial details
- NCT number
- NCT02458651
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-06-26
- Primary completion
- 2018-10-30
- Enrollment
- 1378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.